{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:11:21Z","timestamp":1793211081175,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) has a high recurrence rate even after curative hepatectomy. Circulating tumor cells (CTCs) have emerged as promising liquid biopsy biomarkers for minimal residual disease and early recurrence. This study evaluated longitudinal CTC dynamics and their prognostic significance in HCC patients undergoing curative resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We prospectively analyzed CTCs in 27 HCC patients at four time points: preoperatively, immediately postoperatively, and at 6 and 12 months after surgery. CTCs were defined as CD45\u207b\/CD146\u207a\/ASGPR\u207a using multicolor flow cytometry and immunofluorescence. Recurrence-free survival (RFS) and overall survival (OS) were assessed during a median 3.7-year follow-up. Control groups included 29 patients with non-malignant or non-HCC liver tumors and 8 healthy donors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Preoperative CTCs were detected in 48.2% of HCC patients (mean 0.46 cells\/mL). Detection rates rose to 95% at 6 months and 100% at 12 months post-surgery. Persistent or rising postoperative CTCs were strongly associated with early recurrence (51.8% overall) and reduced RFS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02) and OS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05). No significant correlation was observed between CTC levels and tumor size or volume, AFP, or IL-6 levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Longitudinal CTC monitoring provides an early and non-invasive indicator of recurrence risk and survival after curative HCC resection. Persistent CTCs may represent minimal residual disease and a potential therapeutic target for improving long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15638-7","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:37:32Z","timestamp":1769650652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal monitoring of circulating tumor cell dynamics for potential prediction of early recurrence and clinical outcomes after curative resection of hepatocellular carcinoma: a pilot study"],"prefix":"10.1186","volume":"26","author":[{"given":"Dhruvajyoti","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Guckelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie","family":"Oppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"B\u00fcdeyri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Chaikhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kostantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Zokai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Knaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Katou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Morgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Struecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir P.","family":"Zharov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schnitzbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf O.","family":"Bechstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen A.","family":"Juratli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"6","key":"15638_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"15638_CR2","first-page":"1907","volume":"362","author":"J Llovet","year":"2003","unstructured":"Llovet J, Burroughs A. Bruix Hepatocellular Carcinoma Lancet. 2003;362:1907\u201317.","journal-title":"Bruix Hepatocellular Carcinoma Lancet"},{"key":"15638_CR3","doi-asserted-by":"crossref","unstructured":"Llovet J, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M et al. Hepatocellular carcinoma. Nature reviews. Disease primers. 2016;2:16018.","DOI":"10.1038\/nrdp.2016.18"},{"issue":"1","key":"15638_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/2210309011202010036","volume":"2","author":"O Leis","year":"2012","unstructured":"Leis O, Lopez-Mato P, Martin G. Circulating tumor stem cells as biomarkers for cancer progression. Recent Pat Biomarkers. 2012;2(1):36\u201353.","journal-title":"Recent Pat Biomarkers"},{"key":"15638_CR5","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900425","author":"Y Matsumura","year":"2019","unstructured":"Matsumura Y, Ito Y, Mezawa Y, Sulidan K, Daigo Y, Hiraga T, et al. Stromal fibroblasts induce metastatic tumor cell clusters via epithelial\u2013mesenchymal plasticity. Life Sci Alliance. 2019;2(4). https:\/\/doi.org\/10.26508\/lsa.201900425.","journal-title":"Life Sci Alliance"},{"issue":"1","key":"15638_CR6","doi-asserted-by":"crossref","first-page":"18686","DOI":"10.1038\/s41598-022-21888-9","volume":"12","author":"T Prasoppokakorn","year":"2022","unstructured":"Prasoppokakorn T, Buntho A, Ingrungruanglert P, Tiyarattanachai T, Jaihan T, Kulkraisri K, et al. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma. Sci Rep. 2022;12(1):18686.","journal-title":"Sci Rep"},{"issue":"16","key":"15638_CR7","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1158\/0008-5472.CAN-17-2459","volume":"78","author":"L-N Qi","year":"2018","unstructured":"Qi L-N, Xiang B-D, Wu F-X, Ye J-Z, Zhong J-H, Wang Y-Y, et al. Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma. Cancer Res. 2018;78(16):4731\u201344.","journal-title":"Cancer Res"},{"key":"15638_CR8","volume-title":"WMA declaration of Helsinki\u2014Ethical principles for medical research involving human participants","author":"WTWM Association","year":"2024","unstructured":"Association WTWM. WMA declaration of Helsinki\u2014Ethical principles for medical research involving human participants. WMA: Ferney-Voltaire, France.; 2024."},{"issue":"2","key":"15638_CR9","doi-asserted-by":"crossref","first-page":"e0246527","DOI":"10.1371\/journal.pone.0246527","volume":"16","author":"TJ Vogl","year":"2021","unstructured":"Vogl TJ, Riegelbauer LJ, Oppermann E, Kostantin M, Ackermann H, Trzmiel A, et al. Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma. PLoS One. 2021;16(2):e0246527.","journal-title":"PLoS One"},{"issue":"2","key":"15638_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jamcollsurg.2005.10.005","volume":"202","author":"SA Shah","year":"2006","unstructured":"Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006;202(2):275\u201383.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"15638_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.hpb.2019.09.006","volume":"22","author":"H Xing","year":"2020","unstructured":"Xing H, Zhang W-G, Cescon M, Liang L, Li C, Wang M-D, et al. Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study. HPB. 2020;22(5):677\u201389.","journal-title":"HPB"},{"issue":"1","key":"15638_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/cancers15010232","volume":"15","author":"C Toubert","year":"2022","unstructured":"Toubert C, Guiu B, Al Taweel B, Assenat E, Panaro F, Souche F-R, et al. Prolonged survival after recurrence in HCC resected patients using repeated curative therapies: never give up! Cancers. 2022;15(1):232.","journal-title":"Cancers"},{"issue":"1","key":"15638_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.21037\/hbsn-22-579","volume":"13","author":"A Herrero","year":"2024","unstructured":"Herrero A, Toubert C, Bedoya JU, Assenat E, Guiu B, Panaro F, et al. Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives. Hepatobiliary Surg Nutr. 2024;13(1):71\u201388.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"15638_CR14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/annonc\/mdp391","volume":"21","author":"F-C Bidard","year":"2010","unstructured":"Bidard F-C, Mathiot C, Delaloge S, Brain E, Giachetti S, De Cremoux P, et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol. 2010;21(4):729\u201333.","journal-title":"Ann Oncol"},{"issue":"1","key":"15638_CR15","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-014-0507-6","volume":"17","author":"M Mego","year":"2015","unstructured":"Mego M, Giordano A, De Giorgi U, Masuda H, Hsu L, Giuliano M, et al. Circulating tumor cells in newly diagnosed inflammatory breast cancer. Breast Cancer Res. 2015;17(1):2.","journal-title":"Breast Cancer Res"},{"key":"15638_CR16","first-page":"113","volume-title":"Surgical margins for hepatocellular carcinoma","author":"G Berardi","year":"2022","unstructured":"Berardi G, Guglielmo N, Mariano G, Ettorre GM. Surgical margins for hepatocellular carcinoma. Hepatocellular Carcinoma: Springer International Publishing Cham; 2022. pp. 113\u201320."},{"issue":"8","key":"15638_CR17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00432-011-0988-y","volume":"137","author":"Y-F Sun","year":"2011","unstructured":"Sun Y-F, Yang X-R, Zhou J, Qiu S-J, Fan J, Xu Y. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol. 2011;137(8):1151\u201373.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"15638_CR18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","volume":"29","author":"R Nevola","year":"2023","unstructured":"Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, et al. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol. 2023;29(8):1243.","journal-title":"World J Gastroenterol"},{"key":"15638_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10030144","author":"CY Wu","year":"2020","unstructured":"Wu CY, Lee CL, Wu CF, Fu JY, Yang CT, Wen CT, et al. Circulating tumor cells as a tool of minimal residual disease can predict lung cancer recurrence: a longitudinal, prospective trial. Diagnostics (Basel). 2020;10(3). https:\/\/doi.org\/10.3390\/diagnostics10030144.","journal-title":"Diagnostics"},{"issue":"4","key":"15638_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10585-018-9896-8","volume":"35","author":"M Alieva","year":"2018","unstructured":"Alieva M, van Rheenen J, Broekman ML. Potential impact of invasive surgical procedures on primary tumor growth and metastasis. Clin Exp Metastasis. 2018;35(4):319\u201331.","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"15638_CR21","doi-asserted-by":"crossref","DOI":"10.3390\/cells14070488","volume":"14","author":"A Nishida","year":"2025","unstructured":"Nishida A, Andoh A. The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis. Cells. 2025;14(7):488.","journal-title":"Cells"},{"issue":"20","key":"15638_CR22","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","volume":"10","author":"WJ Allard","year":"2004","unstructured":"Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897\u2013904.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"15638_CR23","doi-asserted-by":"crossref","DOI":"10.3390\/cells14010006","volume":"14","author":"I B\u00fcdeyri","year":"2024","unstructured":"B\u00fcdeyri I, Guckelberger O, Oppermann E, Roy D, Sliwinski S, Becker F, et al. Ezrin polarization as a diagnostic marker for circulating tumor cells in hepatocellular carcinoma. Cells. 2024;14(1):6.","journal-title":"Cells"},{"issue":"1","key":"15638_CR24","volume":"23","author":"Z Lu","year":"2023","unstructured":"Lu Z, Ni H, Yang X, Tan L, Zhuang H, Mo Y, et al. Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy. BMC Cancer. 2023;23(1):1150.","journal-title":"BMC Cancer"},{"issue":"22","key":"15638_CR25","doi-asserted-by":"crossref","DOI":"10.3390\/cells12222590","volume":"12","author":"M Capuozzo","year":"2023","unstructured":"Capuozzo M, Ferrara F, Santorsola M, Zovi A, Ottaiano A. Circulating tumor cells as predictive and prognostic biomarkers in solid tumors. Cells. 2023;12(22):2590.","journal-title":"Cells"},{"issue":"19","key":"15638_CR26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910612","volume":"25","author":"A Fabisiewicz","year":"2024","unstructured":"Fabisiewicz A, Szostakowska-Rodzos M, Grzybowska EA. Improving the prognostic and predictive value of circulating tumor cell enumeration: is longitudinal monitoring the answer? Int J Mol Sci. 2024;25(19):10612.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"15638_CR27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/cncy.22304","volume":"128","author":"YF Sun","year":"2020","unstructured":"Sun YF, Wang PX, Cheng JW, Gong ZJ, Huang A, Zhou KQ, et al. Postoperative Circulating tumor cells: an early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection. Cancer Cytopathol. 2020;128(10):733\u201345.","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"15638_CR28","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1007\/s00432-023-04834-8","volume":"149","author":"J-J Yu","year":"2023","unstructured":"Yu J-J, Li Y-N, Shu C, Yang H-Y, Huang Z, Tao R, et al. Prognostic value of preoperative circulating tumor cells for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. J Cancer Res Clin Oncol. 2023;149(11):8981\u201391.","journal-title":"J Cancer Res Clin Oncol"},{"key":"15638_CR29","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S177663","author":"G Wu","year":"2018","unstructured":"Wu G, Wu J, Wang B, Zhu X, Shi X, Ding Y. Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival: a population-based study. Cancer Manag Res. 2018:4401\u201310. https:\/\/doi.org\/10.2147\/CMAR.S177663.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"15638_CR30","doi-asserted-by":"crossref","DOI":"10.1186\/s41236-018-0009-z","volume":"2","author":"R Oklu","year":"2018","unstructured":"Oklu R, Sheth R, Albadawi H, Bhan I, Sarioglu AF, Choz M, et al. Relationship between hepatocellular carcinoma circulating tumor cells and tumor volume. Cancer Convergence. 2018;2(1):2.","journal-title":"Cancer Convergence"},{"key":"15638_CR31","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9487938","volume":"2018","author":"V Cuccurullo","year":"2018","unstructured":"Cuccurullo V, Di Stasio GD, Mazzarella G, Cascini GL. Microvascular invasion in HCC: the molecular imaging perspective. Contrast Media Mol Imaging. 2018;2018:9487938.","journal-title":"Contrast Media Mol Imaging"},{"issue":"52","key":"15638_CR32","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21208","volume":"8","author":"J von Felden","year":"2017","unstructured":"von Felden J, Schulze K, Krech T, Ewald F, Nashan B, Pantel K, et al. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection. Oncotarget. 2017;8(52):89978.","journal-title":"Oncotarget"},{"key":"15638_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102908","author":"E Galli","year":"2025","unstructured":"Galli E, Patelli G, Villa F, Gri N, Mazzarelli C, Mangoni I, et al. Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: a systematic review. Cancer Treat Rev. 2025:102908. https:\/\/doi.org\/10.1016\/j.ctrv.2025.102908.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"15638_CR34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102476","volume":"13","author":"V Amado","year":"2021","unstructured":"Amado V, Gonz\u00e1lez-Rubio S, Zamora J, Alejandre R, Espejo-Cruz ML, Linares C, et al. Clearance of circulating tumor cells in patients with hepatocellular carcinoma undergoing surgical resection or liver transplantation. Cancers. 2021;13(10):2476.","journal-title":"Cancers"},{"issue":"1","key":"15638_CR35","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03600-1","volume":"24","author":"R Solhi","year":"2024","unstructured":"Solhi R, Pourhamzeh M, Zarrabi A, Hassan M, Mirzaei H, Vosough M. Novel biomarkers for monitoring and management of hepatocellular carcinoma. Cancer Cell Int. 2024;24(1):428.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"15638_CR36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1373\/clinchem.2012.194258","volume":"59","author":"C Alix-Panabi\u00e8res","year":"2013","unstructured":"Alix-Panabi\u00e8res C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2013;59(1):110\u20138.","journal-title":"Clin Chem"},{"issue":"19","key":"15638_CR37","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","volume":"26","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of Circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(19):3213\u201321.","journal-title":"J Clin Oncol"},{"issue":"6119","key":"15638_CR38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339(6119):580\u20134.","journal-title":"Science"},{"issue":"1","key":"15638_CR39","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"17","key":"15638_CR40","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.21037\/atm-20-2751","volume":"8","author":"Z Chen","year":"2020","unstructured":"Chen Z, Lin X, Chen C, Chen Y, Zhao Q, Wu L, et al. Analysis of preoperative Circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation. Ann Transl Med. 2020;8(17):1067.","journal-title":"Ann Transl Med"},{"issue":"1","key":"15638_CR41","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"15638_CR42","volume":"13","author":"X Guo","year":"2025","unstructured":"Guo X, Zhao Z, Zhu L, Liu S, Zhou L, Wu F, et al. The evolving landscape of biomarkers for systemic therapy in advanced hepatocellular carcinoma. Biomark Res. 2025;13(1):60.","journal-title":"Biomark Res"},{"issue":"3","key":"15638_CR43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/ceh.2018.78122","volume":"4","author":"E Shakiba","year":"2018","unstructured":"Shakiba E, Ramezani M, Sadeghi M. Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis. Clin Exp Hepatol. 2018;4(3):182\u201390.","journal-title":"Clin Exp Hepatol"},{"issue":"22","key":"15638_CR44","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223698","volume":"11","author":"M Ra\u0161kov\u00e1","year":"2022","unstructured":"Ra\u0161kov\u00e1 M, Lacina L, Kej\u00edk Z, Venhauerov\u00e1 A, Skali\u010dkov\u00e1 M, Kol\u00e1\u0159 M, et al. The role of IL-6 in cancer cell invasiveness and metastasis\u2014overview and therapeutic opportunities. Cells. 2022;11(22):3698.","journal-title":"Cells"},{"key":"15638_CR45","doi-asserted-by":"publisher","DOI":"10.1039\/D5AY01320H","author":"L Liu","year":"2025","unstructured":"Liu L, Qu L, Wu X, Wang Z, He S, Liu Z, et al. Detection and indications of Circulating tumor cells in hepatocellular carcinoma. Anal Methods. 2025. https:\/\/doi.org\/10.1039\/D5AY01320H.","journal-title":"Anal Methods"},{"issue":"9","key":"15638_CR46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/sj.bjc.6605651","volume":"102","author":"G Peach","year":"2010","unstructured":"Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P. Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review. Br J Cancer. 2010;102(9):1327\u201334.","journal-title":"Br J Cancer"},{"issue":"9","key":"15638_CR47","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ejso.2008.12.003","volume":"35","author":"J Wind","year":"2009","unstructured":"Wind J, Tuynman J, Tibbe A, Swennenhuis J, Richel D, van Berge Henegouwen M, et al. Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. Eur J Surg Oncol (EJSO). 2009;35(9):942\u201350.","journal-title":"Eur J Surg Oncol (EJSO)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15638-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:17:46Z","timestamp":1781630266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15638-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15638"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15638-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the University of Frankfurt (approval number: 312\/16). Informed consent forms were signed by all the patients. Informed consent forms were signed and obtained by all the patients. This article does not contain any studies with animal subjects. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}